TRIM6 and central nervous system cancer: According to the TCGA database, TRIM6 expression can be considered a discriminatory factor based on the ROC analysis, with an area under the curve (AUC) of 0.821, indicating its potential as a diagnostic biomarker for Gliomas relative to normal tissue (Figure 4A).